Solubility Data as a Response for a Challenge for Formulation Chemists: Imidazolium-Based Ionic Liquids and Antitubercular Antibiotic Medicines Faria, R.A.M.; Vieira, T.F.M.; Melo, C.I.; Bogel-Łukasik, E.; Journal of Chemical & Engineering Data 2016, 61, 3116-3126
Data
P = 101 kPa
x (mol mol-1) TSLE (K)
0.0410 283.74
0.1548 326.26
0.1602 327.37
0.1696 329.19
0.1819 331.43
0.1859 332.12
0.2086 335.81
0.2127 336.45
0.2447 340.92
0.2540 342.12
0.2759 344.77
0.0423 284.74
0.3305 350.55
0.3380 351.27
0.4066 357.18
0.4075 357.25
0.4221 358.38
0.4534 360.67
0.4691 361.76
0.475 362.16
0.4991 363.75
0.5290 365.61
0.0451 286.79
0.5621 367.55
0.5823 368.68
0.6107 370.21
0.6390 371.65
0.6939 374.29
0.7314 375.98
0.7492 376.75
0.7875 378.34
0.8123 379.34
0.8302 380.03
0.0614 296.65
0.8683 381.47
0.8962 382.48
0.9264 383.54
0.9548 384.51
1 461.42
0.0748 302.99
0.1137 316.4
0.1272 319.98
0.1430 323.74
0.1464 324.49
1391; pyrazinamide + 1-butyl-3-methylimidazolium tetrafluoroborate; 00009:00485